Artelo Biosciences, Inc. (ARTL)
NASDAQ·Healthcare·Biotechnology
$3.51
-6.80%
Mkt Cap $2.55M
No analyst coverage available
We don't have analyst ratings or price target data for Artelo Biosciences, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.